All In Biotech

Drug Trial Radar · NCT00751959

Surfactant Application During Spontaneous Breathing With Continuous Positive Airway Pressure (CPAP) in Premature Infants < 27 Weeks

Surfactant Application During Spontaneous Breathing With CPAP or During Mechanical Ventilation in the Therapy of IRDS in Premature Infants < 27 Weeks

Last checked: Nov 20, 2026Latest source record: Jul 19, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 213 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

213

Actual

Start

Apr 2009

Primary completion

Jun 2012

Study completion Jun 2012

Sponsor

Lead sponsor
University of CologneAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University Hopsital Schleswig Holstein Campus Lübeck; Altona Children's Hospital; Ruhr University of Bochum; Vestische Kinder- und Jugendklinik Datteln; Hospital of Leverkusen; Kliniken der Stadt Koeln, Kinderkrankenhaus Riehl; Heinrich-Heine University, Duesseldorf; Klinikum Aschaffenburg-Alzenau; Asklepios Kliniken Hamburg GmbH; Klinikum Stuttgart; DRK Kinderklinik Siegen; University Hospital, Bonn; Charite University, Berlin, Germany; The Clinical Trials Centre Cologne; German Federal Ministry of Education and Research
First posted
Sep 12, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 23 weeks, up to 26 weeks
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study investigates the efficacy of surfactant application during spontaneous breathing with CPAP in avoiding death and chronic lung disease (CLD) in very immature infants with a gestational age of less than 27 weeks.

Conditions

  • Respiratory Distress Syndrome, Newborn

Interventions

  • CurosurfDrug

    Surfactant application via a thin endotracheal catheter during spontaneous breathing with CPAP, followed by respiratory support with CPAP

  • CurosurfDrug

    Conventional therapy with intubation, initiation of mechanical ventilation and surfactant application

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Survival until term without CLDTime frame: 13-17 weeks after birth

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Klinikum Aschaffenburg, Klinik für Kinder- und Jugendmedizin

    Aschaffenburg, Germany

  • Charité

    Berlin, Germany

  • Ruhr University of Bochum, Children's Hospital St. Josef Spital

    Bochum, Germany

  • University Hospital, Dept. of Neonatology

    Bonn, Germany

  • Kliniken der Stadt Koeln, Kinderkrankenhaus Riehl

    Cologne, Germany

  • University of Cologne, Clinic for Paediatrics

    Cologne, Germany

  • Vestische Kinder- und Jugendklinik

    Datteln, Germany

  • University Hospital, Clinic for Paediatrics

    Düsseldorf, Germany

  • Asklepios Klinik Barmbek

    Hamburg, Germany

  • Hospital of Leverkusen, Dept. of Children's Medicine

    Leverkusen, Germany

  • University Hospital of Schleswig-Holstein, Campus Lübeck, Dept. of Children's Medicine

    Lübeck, Germany

  • DRK Kinderklinik

    Siegen, Germany

  • Klinikum Stuttgart, Olgahospital

    Stuttgart, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.